Literature DB >> 17364498

Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.

Stephanie J Ramos1, Jenny L Hardison, Linda N Stiles, Thomas E Lane, Craig M Walsh.   

Abstract

The signaling events involved in T cell trafficking into the central nervous system (CNS) following viral infection are not fully understood. Intracerebral infection of mice with mouse hepatitis virus (MHV) results in an acute encephalomyelitis followed by an immune-mediated demyelinating disease. Although chemokine signaling is critical in promoting T cell infiltration into the CNS and control of viral replication, additional signaling pathways have not been completely explored. DRAK2, a lymphoid-restricted serine/threonine kinase, prevents spurious T cell activation. Yet Drak2- / - mice are resistant to MOG-induced experimental autoimmune encephalomyelitis (EAE), suggesting that DRAK2 may influence T cell trafficking into the CNS. In order to further characterize the molecular mechanisms governing T cell activation and accumulation within the CNS in response to viral infection, MHV was instilled into the CNS of Drak2- / - mice. Drak2-deficient T cells possessed no obvious defects in trafficking into the CNS following MHV infection. Moreover, Drak2-deficient T cell activation, expansion and cytokine production were unimpaired in response to acute MHV infection. These results demonstrate that DRAK2 signaling is dispensable for T cell recruitment into the CNS following viral infection, suggesting that the resistance of Drak2- / - mice to EAE is not due to overt T cell trafficking defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364498     DOI: 10.1080/08916930600996700

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

1.  Drak2 is not required for tumor surveillance and suppression.

Authors:  Benjamin A Edwards; Tarsha L Harris; Helen Floersh; John R Lukens; Md Hasan Zaki; Peter Vogel; Thirumala-Devi Kanneganti; Jack D Bui; Maureen A McGargill
Journal:  Int Immunol       Date:  2015-01-07       Impact factor: 4.823

2.  Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity.

Authors:  Jennifer V Lu; Brian M Weist; Bram J van Raam; Brett S Marro; Long V Nguyen; Prathna Srinivas; Bryan D Bell; Keith A Luhrs; Thomas E Lane; Guy S Salvesen; Craig M Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

3.  Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation.

Authors:  Ryan H Newton; Sabrina Leverrier; Sonal Srikanth; Yousang Gwack; Michael D Cahalan; Craig M Walsh
Journal:  J Immunol       Date:  2010-12-10       Impact factor: 5.422

4.  Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses.

Authors:  B M Weist; J B Hernandez; C M Walsh
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

5.  A role for DRAK2 in the germinal center reaction and the antibody response.

Authors:  Ahmed Al-Qahtani; Zhenming Xu; Hong Zan; Craig M Walsh; Paolo Casali
Journal:  Autoimmunity       Date:  2008-08       Impact factor: 2.815

6.  Enhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity.

Authors:  Stephanie J Ramos; Jeniffer B Hernandez; Martina Gatzka; Craig M Walsh
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.

Authors:  Maureen A McGargill; Carmen Choy; Ben G Wen; Stephen M Hedrick
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.

Authors:  Martina Gatzka; Ryan H Newton; Craig M Walsh
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  Drak2 Does Not Regulate TGF-β Signaling in T Cells.

Authors:  Tarsha L Harris; Maureen A McGargill
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

10.  Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis.

Authors:  Shuhui Wang; Thomas Welte; Maureen McGargill; Terrence Town; Jesse Thompson; John F Anderson; Richard A Flavell; Erol Fikrig; Stephen M Hedrick; Tian Wang
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.